SOURCE-LINKED INTELLIGENCE

BIOmarker based diagnostic TOOLkit to personalize pharmacological approaches in congestive heart failure

CORDIS · observation · Publication date unknown

ts symptoms, and achieve target guideline-directed medical therapy. To fill these gaps, BIOTOOL-CHF will 1) validate a set of qualified biomarkers estimating congestion, 2) define a multiparametric artificial intelligence-based score predicting congestion and prognosis, 3) develop a decision-making tool to manage congestion by diuretics, 4) develop a Point of Care companion diagnostic (CD) to assess biomarkers concentrations 5) set up a Strategy plan for industrial development and market access of the CD. This approach will support the definition of a framework to regulatory agencies and scientific societies to disseminate recommendations for a more efficient use of existing pharmaceuticals and allow a personalised strategy for the management of HFrEF, by using new tools and digital solutions. Heart failure, Personalized medicine, Valued-based medicine, Biomarkers, Artificial Intelligence, Companion diagnostic, Decision-making tool, Quality of Life, Diuretics, Congestion

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

9600663

unit

EUR